Objective: To investigate a correlation between preoperative non-echo planar diffusion-weighted magnetic resonance imaging (non-EPI DW MRI) with surgical findings of localization and extension of cholesteatoma and to develop criteria for surgical planning. Patients: Preoperative non-EPI DWMRI was available and positive for cholesteatoma in 27 patients with primary and 23 with residual/recurrent lesions. Interventions: Patients with cholesteatoma limited to the middle ear and its extensions were managed with a transcanal endoscopic approach. Patients with extension of the cholesteatoma posteriorly to the lateral semicircular canal underwent retroauricular mastoidectomy combined with an endoscopic approach. Main Outcome Measure: Comparison of preoperative radiologic to surgical findings. Results: DWI showed isolated tympanic and attic extension in 33 cases and attico-antral and mastoid extension in 17 cases.
MRI findings correlated with surgical findings in all patients with primary cholesteatoma, 19 of whom were managed with a transcanal endoscopic approach and 8 with endoscope-assisted ear surgery. The transcanal endoscopic approach was applied in 14 of the patients with residual/recurrent cholesteatoma, and the other 9 residual/recurrent lesions were eradicated using endoscopeassisted mastoidectomy. DWI overestimated cholesteatoma sites in 1 patient with residual lesion. The smallest cholesteatoma detected on DWI was a 3-mm lesion in the middle ear over the facial nerve. Conclusion: Primary and residual/recurrent cholesteatoma was accurately detected on non-EPI DWI with 98% clinical and radiologic concordance. Lesions less than 8 mm confined to the middle ear and its extensions can be eradicated with a minimally invasive endoscopic transcanal technique, whereas endoscopeassisted retroauricular mastoidectomy is preferred for larger lesions. Key words: CholesteatomaVImagingVSurgery. Otol Neurotol 35:121Y125, 2014.
Non-echo planar (non-EPI) diffusion-weighted (DW) magnetic resonance imaging (MRI) has emerged as the optimal imaging technique for diagnosing the presence and extent of cholesteatoma. Recent studies have already shown a high correlation between preoperative non-EPI DWI and findings at surgery, demonstrating that DWMRI can accurately predict the presence of cholesteatoma in both primary and residual cases. The application of non-EPI DWI with a detection limit for a cholesteatoma as low as 2 mm is rapidly becoming a widely accepted practice in the postoperative follow-up of these patients (1Y14).
The surgical management of cholesteatoma tends to use the least invasive surgical techniques (15Y18). The choice of surgical approach depends on the extension of the disease and on the preoperative otoscopic and radiologic findings. Cholesteatoma is usually endoscopically accessible when the lesion does not involve the mastoid beyond the level of the lateral semicircular canal (15) , whereas mastoid obliteration techniques can be used in more extended cases (19) . The growing utilization of endoscopic procedures in the eradication of cholesteatoma requires precise preoperative imaging data for assistance in optimal planning of endoscopic ear surgery (EES) or endoscope-assisted ear surgery (EAES).
The objective of the present work was to investigate a correlation between preoperative non-EPI DWI and surgical findings in terms of localization and extension of primary and residual/recurrent cholesteatoma and to develop criteria for surgical technique planning. This is the first study to present the results of endoscopic or endoscope-assisted ear surgeries that were planned according to the preoperative non-EPI DW MRI findings.
METHODS
Only the surgeries performed by the same surgeon (L. M.) were analyzed in the current study. Between July 2008 and June 2013, an endoscopic approach was applied in 185 surgeries, of which, 120 were performed for primary (n = 87) or residual/ recurrent cholesteatoma (n = 33) that had been operated elsewhere. Preoperative non-EPI DWMRI was available and positive for cholesteatoma in 27 patients with primary disease and in 23 patients with residual/recurrent lesion. Patients who were preoperatively assessed solely by computerized tomography or EPI MRI were excluded to achieve homogeneity of preoperative assessment. The diagnosis of cholesteatoma was verified histologically. MRI studies were carried on 3T scanners using a combination of standard head/IAC protocol, applying both conventional sequences together with non-EPI-based diffusionweighted images. Our imaging studies included 2 non-EPI techniques, a coronal HASTE DWI (half-Fourier acquisition single-shot turbo spin-echo) or an axial PROPELLER DWI (multishot fast spin-echo periodically rotated overlapping parallel lines with enhanced reconstruction). Both non-EPI sequences are highly sensitive for detection of the keratinized content of cholesteatomas (1Y14). MRI studies were analyzed by one of the neuroradiologists (G. G. or A. E.) in cooperation with a surgeon (L. M.). Transcanal endoscopic surgical technique is well described previously and is beyond the scope of the current article (15Y18). Surgical findings were compared with preoperative findings on DWI. A lesion found posterior to the posterior limb of the lateral semicircular canal (LSCC) was defined as being within the mastoid (14) .
RESULTS
The study cohort was composed of 29 male and 21 female subjects aged 4 to 70 years (mean, 29.2 yr). The non-EPI DW MRI studies revealed isolated tympanic and attic extension in 33 cases and attico-antral and mastoid extension in 17 cases. Patients with cholesteatoma limited to the middle ear and its extensions were managed solely with a transcanal endoscopic approach (Figs. 1Y3). Extension posteriorly to the LSCC was the criterion for performing traditional retroauricular mastoidectomy combined with an endoscopic approach (Figs. 4Y6).
Nineteen of the 27 patients in the primary cholesteatoma group were managed with transcanal EES, and the remaining 8 underwent EAES (3 canal wall-up [CWU] and 3 canal wall down [CWD] mastoidectomies without mastoid obliteration and 2 CWU mastoidectomies with mastoid obliteration). The MRI findings correlated with the surgical findings in all 27 patients. Up to now, postoperative non-EPI DWMRI was performed in 11 of 19 patients who underwent transcanal EES and in 3 of 8 who underwent EAES. The only one positive to cholesteatoma in the attic MRI was in patient who was treated with transcanal EES. The patient is scheduled for revision surgery.
Exclusive transcanal EES was carried out in 14 patients with residual/recurrent lesion and EAES was performed in the remaining 9 (1 CWU, 2 radical mastoidectomies, and 6 CWD with mastoid obliteration). The MRI of 1 patient showed a few punctate hyperintensities of 2 mm in the middle ear and its extensions; however, only one 4-mm lesion was found over the tympanic portion of the facial nerve during surgery. The other sites that were positive for cholesteatoma on MRI were attributed to the presence of cartilage that was used for reconstruction in the previous surgery. The MRI findings correlated with the surgical findings in 22 (95.6%) of 23 cases in this group. To date, postoperative non-EPI DWMRI was performed in 9 of 14 patients who underwent transcanal EES and in 5 of 9 who underwent EAES and did not detect cholesteatoma in these 14 cases.
Non-EPI DW MRI detected the precise localization and extension of cholesteatoma in 49 (98%) of 50 cases, with overestimation of the number of cholesteatoma sites in the middle ear and attic of only 1 patient who had already undergone intervention for cholesteatoma in the past. The smallest lesion that had been detected on MRI and resected with an endoscopic transcanal approach was 3 mm, and it was located in the middle ear over the facial nerve. There was some tendency toward underestimation (1 mm) of the cholesteatoma size in 5 patients with primary lesions, possibly because of the delay between the MRI and surgery (range, 2 wk to 6 mo).
Labyrinthine invasion by the cholesteatoma and tegmen tympani erosion was demonstrated on DWI and found at surgery in 2 cases each. The labyrinthine fistula did not involve the endosteal membrane, and it was located in the lateral semicircular canal in both patients. The matrix was easily removed, and the fistula was occluded by bone wax. A cholesteatoma-induced defect of the bony external auditory canal was detected on DWI and observed intraoperatively in 3 cases.
Thirty-three cases in which non-EPI DW MRI showed the cholesteatoma as being limited to the middle ear and extensions, measuring less than 8 mm and not extending posteriorly to the LSCC, were managed with EES. The endoscope served as a valuable addition to the microscope for enhanced visualization of the sinus tympani, facial recess, eustachian tube, supratubal recess, and hypotympanum in 17 cases of more extensive cholesteatoma.
DISCUSSION
Assessment of the anatomic extent of a cholesteatoma based of contemporary radiologic imaging is essential for planning the optimal surgical approach. Transcanal EES is difficult 1-hand surgery, technically possible only for highly skilled otosurgeons. The experience in performing traditional mastoidectomy and tympanoplasty using the microscope is obligatory before starting the endoscopic approach for eradication of the cholesteatoma. Some difficulties in manipulation of the instruments in patients with narrow ear canal and young children can be overcome with extensive experience and use of appropriate sets including a 3-mm diameter endoscopes, curved instruments and suction tips.
Our experience shows that lesions less than 8 mm in size and confined to the middle ear or its extensions can be eradicated exclusively by a transcanal endoscopic approach, whereas larger lesions should be managed with EAES. The possibility of a labyrinthine fistula in cases of extension of the cholesteatoma posteriorly to the labyrinth must be taken into consideration.
High-resolution computed tomography (CT) can depict the anatomy of the middle ear and mastoid, predict the involvement of the sinus tympani and facial recess, and has excellent spatial resolution allowing delineation of small soft-tissue masses against bony structures and air (20) . To date, CT of the temporal bones is considered as an initial tool to detect cholesteatoma in many departments worldwide. Thus, part of the patients still arrive for preoperative counseling in our hospital with a CT scans, and the patients with images demonstrating wellaerated mastoid and lesions limited to the middle ear cavity are not required to complete the preoperative investigation with the MRI. However, CT is mostly performed when the ear is inflamed and has poor value in distinguishing a cholesteatoma from the inflammatory tissue, granulations, fibrosis, or mucoid secretions in 20% to 70% of cases showing nonspecific opacification of the middle ear and mastoid (21) . This is the main reason that, in most cases, it is impossible to diagnose or exclude the presence of a cholesteatoma or to predict its extension on the basis of CT findings and why there is a little benefit of CT in managing these patients. Advances in MRI techniques changed the protocols for the preoperative evaluation and the postoperative follow-up for cases of cholesteatoma resulted in minimizing radiation exposure, especially in children. In our opinion, preoperative CT scan can be helpful but not replace MRI in complicated cases associated with intracranial extension of cholesteatoma, facial nerve impaired movement, disequilibrium or deafness, to better understanding of the bony invasion by the cholesteatoma.
Non-EPI DW imaging performs reasonably well in predicting the presence and location of postoperative cholesteatoma but may miss small foci of disease and may underestimate the true size of cholesteatoma (14) . In our series, the smallest cholesteatoma detected by DWI and whose size and location were confirmed at surgery was a 3-mm lesion confined to the anterior attic. Correlation of preoperative radiologic images with intraoperative clinical findings was good with regard to tympanic and mastoid cholesteatoma but weak in cases of facial canal dehiscence. The latter was found intraoperatively in 15 (30%) of 50 cases. This is of little clinical importance, however, since all endoscopic and endoscope-assisted surgeries are routinely performed under facial nerve monitoring in our department. Notably, cartilage that had been used for previous reconstructions can lead to misdiagnosis because it may appear as increased DW signal intensity resembling cholesteatoma. Nevertheless, non-EPI DWI was found as useful tool in predicting localization of cholesteatoma and estimation of its extension. Moreover, the findings of non-EPI DWI altered patient management, particularly in these who underwent cholesteatoma surgery in the past and in whom an adequate clinical inspection of the middle ear or mastoid cavity was impossible.
Our study has some limitations. One of them stems from the difficulty in estimating the exact size of a lesion in cases of diffuse or open cholesteatoma when dissection, irrigation, and suctioning are applied during the surgery. Our observation of there being some tendency for radiologic assessment to underestimate the true size of lesion, possibly attributable to a delay between imaging and surgery, is in agreement with the findings of Khemani et al. (14) . In addition, the slice thickness of the non-EPI DW images usually cannot differentiate between cholesteatoma in the facial recess and cholesteatoma in the sinus tympani (14) . However, transcanal introduction of variously angulated endoscopes can be used in the assessment of these middle ear structures, and appropriately curved micro-instruments and suction tips can be used for completion of cholesteatoma eradication from these hidden areas.
In our experience, non-EPI DWI in its current resolution cannot predict the need in CWD procedure because even large cholesteatomas can be eradicated with endoscopeassisted CWU technique, and sometimes, the location of cholesteatoma requires performing CWD and even radical mastoidectomy. MRI can help in choosing between transcanal endoscopic procedure and endoscope-assisted traditional mastoidectomy. However, the final decision on CWU or CWD technique still depends on the intraoperative finding.
CONCLUSION
Primary and residual/recurrent cholesteatomas were accurately detected by increased DW signal intensity on non-EPI DWI with a 98% clinical and radiologic concordance. Cholesteatoma size and location are crucial factors in choosing the appropriate surgical approach. Lesions that are less than 8 mm in size and confined to the middle ear or its extensions can be eradicated with a minimally invasive endoscopic transcanal technique, whereas endoscope-assisted retroauricular mastoidectomy is the preferable procedure for larger lesions. Skilled interpretation of the images is essential to maximize the value of preoperative imaging because motion artifacts, cartilage used for reconstructions in previous intervention, or cerumen in the external auditory canal can mimic a cholesteatoma and compromise optimal planning of a surgical approach.
